Salgado v. Iqvia, Inc.

District Court, S.D. California·Decided May 8, 2020·No. 3:18-cv-02785·Unknown

Opinion

5 6

7 8 UNITED STATES DISTRICT COURT 9 SOUTHERN DISTRICT OF CALIFORNIA

10 CINDY SALGADO, Case No. 18-cv-2785-BAS-WVG 11 Plaintiff, ORDER: 12 (1) GRANTING IN PART AND DENYING IN PART 13 v. PLAINTIFF’S MOTION FOR PARTIAL SUMMARY 14 IQVIA, INC. and QUINTILES JUDGMENT; AND COMMERCIAL US, INC., (2) DENYING DEFENDANTS’ 15 MOTION FOR PARTIAL Defendants. SUMMARY JUDGMENT 16 [ECF Nos. 28, 29] 17

18 19 Presently before the Court are cross motions for partial summary judgment by 20 Plaintiff Cindy Salgado and Defendants Quintiles Commercial U.S., Inc. and Iqvia 21 Inc. (“Def. Mot.,” ECF No. 28, “Pl. Mot.,” ECF No. 29.) Both motions are opposed, 22 (“Pl. Opp’n,” ECF No. 33, “Def. Opp’n,” ECF No. 34), and both have replies filed 23 in support, (“Def. Reply,” ECF No. 39, “Pl. Reply,” ECF No. 37). The Court finds 24 resolution of these Motions is suitable without the need for oral argument. See Civ. 25 L.R. 7.1(d)(1). For the reasons discussed below, the Court GRANTS IN PART and 26 DENIES IN PART Plaintiff’s Motion and DENIES Defendants’ Motion. 27 I. BACKGROUND 1 11, 2015. (Joint Statement of Undisputed Material Facts, “JSUMF,” ECF No. 38, at 2 ¶ 1.) In November 2017, following a merger, Quintiles became Iqvia, Inc. (Id.)1 3 Iqvia is a global provider of biopharmaceutical development and commercial 4 outsourcing services. (“Vick Decl.,” ECF No. 28-2, ¶ 2.) One of Iqvia’s contracts 5 for biopharmaceutical services is with AbbVie, Inc., a biopharmaceutical company 6 involved in the research, development, marketing, and distribution of 7 biopharmaceutical products, including Humira. (Id. ¶¶ 2–3.) Iqvia has a dedicated 8 workforce to support patient outreach for AbbVie’s Humira business. (Id.) The 9 Humira project includes approximately 200 to 250 “Nurse Ambassadors” who train 10 patients on administering their injections and provide patient care, paperwork help, 11 and other services. (Id. ¶¶ 3–8.) There are about 29 to 30 District Managers who 12 supervise, manage, and train the Nurse Ambassadors. (Id. ¶ 8.) At all times relevant 13 to Plaintiff’s Complaint, Iqvia utilized Unum Group (“Unum”), a third-party leave 14 management service, to administer employees’ leaves of absence. Unum evaluates 15 eligibility for leave, tracks the leave, and ensures compliance with applicable law. 16 (Def. Opp’n at 4.) 17 On May 12, 2016, Plaintiff was promoted to the position of District Manager 18 on the AbbVie/Humira Nurse Ambassador Project for the Southern California 19 Region. Plaintiff began working in that position on May 23, 2016. (JSUMF ¶ 2.) 20 On May 25, 2017, Plaintiff began a leave of absence related to her pregnancy. (Id. 21 ¶ 3.) Unum administered Plaintiff’s leave and disability benefits. (Def. Opp’n at 4.) 22 Plaintiff gave birth to her baby on July 23, 2017. (JSUMF ¶ 4.) Plaintiff’s anticipated 23 return date was November 25, 2017. (“Compl.,” ECF No. 1-1, at ¶ 14.) In October 24 2017, Plaintiff began treatment for postpartum depression and postpartum anxiety. 25 (JSUMF ¶ 15.) She was diagnosed with postpartum depression and received a 26 doctor’s note from Dr. Shahida Parveen to be placed off work through November 1, 27 1 2017. (Exhibit P, ECF No. 34-12.) Plaintiff then received a second note to be placed 2 off work until November 29, 2017, a third note to be off work until December 13, 3 2017, a fourth to be off work until December 29, 2017, and a fifth to be off work 4 until January 10, 2018. (Exhibits Q, R, S, and T, ECF No. 34-13 to 34-16.) 5 On January 8, 2018, Plaintiff sent Human Resources Specialist Christal 6 Carmona an email, attaching a Work Status Note from her healthcare provider 7 providing a return to work date and restrictions. (Exhibit 14, ECF No. 29-16.) 8 Plaintiff requested to return to work on January 16, 2018, working no more than 20 9 hours a week or 4 hours a day for the first and second week and working no more 10 than 30 hours a week or 6 hours a day for the third and fourth weeks. (Id.) 11 On January 11, 2018, Carmona sent Plaintiff an email stating that Iqvia was 12 “unable to support the return to work accommodations” and suggesting that Plaintiff 13 contact her doctor to see if there were any other solutions or schedules that could be 14 provided. (JSUMF ¶ 8.) The same day, Plaintiff responded saying she would follow 15 up with her doctors and asked what modifications Iqvia could support. (Id. ¶ 9.) On 16 January 12, 2018, Iqvia told Plaintiff her employment was terminated, effective that 17 day. (Id. ¶ 10.) On January 16, 2018, Plaintiff received an email from Aliza Zaidi, 18 the Associate Director of Human Resources, explaining the termination. The email 19 stated Iqvia had received Plaintiff’s requested work schedule, and “[a]t this time we 20 are unable to accommodate this request, due [sic] critical business needs and needed 21 to have someone working the territory on a full-time basis, as such we made the 22 decision to terminate your employment . . . .” (Exhibit 18, ECF No. 29-16.) 23 In total, Plaintiff was on a pregnancy-related leave of absence from May 25, 24 2017 through January 12, 2018. Plaintiff’s leave consisted of leave provided for by 25 California’s Pregnancy Disability Leave Law, the California Family Rights Act, and 26 the California Fair Employment Housing Act. (JSUMF ¶ 6.) Unum was responsible 27 for determining whether Plaintiff was eligible for leave, and Iqvia relied on Unum’s 1 In October 2018, Plaintiff filed suit for: (1) discrimination, (2) failure to 2 accommodate, (3) failure to engage in the interactive process, (4) retaliation, (5) 3 interference with leave and violations of California’s Pregnancy Disability Leave 4 Law, (6) interference with leave and violations of the California Family Rights Act, 5 (7) failure to investigate and prevent discrimination, (8) wrongful termination in 6 violation of public policy, (9) violation of California Labor Code section 1030. 7 Plaintiff moves for summary judgment on her first, second, third, sixth, and 8 eighth causes of action. Iqvia moves for summary judgment on Plaintiff’s punitive 9 damages claim. 10 II. LEGAL STANDARD 11 Summary judgment is appropriate under Rule 56(c) where the moving party 12 demonstrates the absence of a genuine issue of material fact and entitlement to 13 judgment as a matter of law. See Fed. R. Civ. P. 56(c); Celotex Corp. v. Catrett, 477 14 U.S. 317, 322 (1986). A fact is material when, under the governing substantive law, 15 it could affect the outcome of the case. Anderson v. Liberty Lobby, Inc., 477 U.S. 16 242, 248 (1986). A dispute about a material fact is genuine if “the evidence is such 17 that a reasonable jury could return a verdict for the nonmoving party.” Id. 18 A party seeking summary judgment always bears the initial burden of 19 establishing the absence of a genuine issue of material fact. Celotex, 477 U.S. at 323. 20 The moving party can satisfy this burden in two ways: (1) by presenting evidence 21 that negates an essential element of the nonmoving party’s case; or (2) by 22 demonstrating that the nonmoving party failed to make a showing sufficient to 23 establish an element essential to that party’s case on which that party will bear the 24 burden of proof at trial. Id. at 322–23. “Disputes over irrelevant or unnecessary facts 25 will not preclude a grant of summary judgment.” T.W. Elec. Serv., Inc. v. Pac. Elec. 26 Contractors Ass’n, 809 F.2d 626, 630 (9th Cir. 1987). 27 If the moving party fails to discharge this initial burden, summary judgment 1 Adickes v. S.H. Kress & Co., 398 U.S. 144, 159–60 (1970).

Free access — add to your briefcase to read the full text and ask questions with AI

Salgado v. Iqvia, Inc., (S.D. Cal. 2020).

Salgado v. Iqvia, Inc. (Salgado v. Iqvia, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Adickes v. S. H. Kress & Co.
398 U.S. 144 (Supreme Court, 1970)
Kennedy v. Allied Mutual Insurance Co.
952 F.2d 262 (Ninth Circuit, 1991)
White v. Ultramar, Inc.
981 P.2d 944 (California Supreme Court, 1999)
Egan v. Mutual of Omaha Insurance
598 P.2d 452 (California Supreme Court, 1979)
Scotch v. Art Institute of California-Orange County, Inc.
173 Cal. App. 4th 986 (California Court of Appeal, 2009)
Nadaf-Rahrov v. the Neiman Marcus Group, Inc.
166 Cal. App. 4th 952 (California Court of Appeal, 2008)
Hanson v. Lucky Stores, Inc.
87 Cal. Rptr. 2d 487 (California Court of Appeal, 1999)
Cruz v. Homebase
99 Cal. Rptr. 2d 435 (California Court of Appeal, 2000)
Wysinger v. AUTOMOBILE CLUB OF SO. CALIF.
69 Cal. Rptr. 3d 1 (California Court of Appeal, 2007)
Jensen v. Wells Fargo Bank
102 Cal. Rptr. 2d 55 (California Court of Appeal, 2000)
Raine v. City of Burbank
37 Cal. Rptr. 3d 899 (California Court of Appeal, 2006)
A.M. v. Albertsons, LLC
178 Cal. App. 4th 455 (California Court of Appeal, 2009)
Pacific Insurance v. Kent
120 F. Supp. 2d 1205 (C.D. California, 2000)
Burch v. Regents of the University of California
433 F. Supp. 2d 1110 (E.D. California, 2006)